• Info
  • Insider Ownership

Insider Trading & Ownership of Tamar D. Howson

Signature
/s/ Tamar Howson
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Tamar D. Howson and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Tamar D. Howson has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value is not available.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Cue Biopharma, Inc. ().
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Tamar D. Howson

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CUE Cue Biopharma, Inc. Director 03 Jan 2023
IMUX IMMUNIC, INC. Director 05 Jun 2025
LITS MEI Pharma, Inc. Director 29 Sep 2023

Insider Transactions Reported by Tamar D. Howson:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored